Search
for
Sort by
Research 30 of 180
- Nonscarring inflammatory alopecia associated with the epidermal growth factor receptor inhibitor gefitinib
- Gefitinib: an adverse effects profile
- Erosive Pustular Dermatosis of the Scalp-Like Eruption due to Gefitinib: Case Report and Review of the Literature of Alopecia Associated with EGFR Inhibitors
- Trichoscopic Findings of Erosive Pustular Dermatosis of the Scalp Associated with Gefitinib
- Gefitinib-induced hair alterations: Figure 1
- Severe Refractory Scarring Alopecia Associated With Combinational Use of Ficlatuzumab (AV-299) and Gefitinib
- Erosive pustular dermatosis of the scalp induced by gefitinib: case and review of the literature
- The Dark Side of Gefitinib: Reflectance Confocal Microscopy Applied to Hair Hyperpigmentation
- An unusual terminal hair growth on the nose tip associated with gefitinib therapy
- Hair Growth After Gefitinib Treatment
- Unexpected hair growth induced by gefitinib treatment in two patients with EGFR gene mutation-positive adenocarcinoma of the lung
- Severe scarring alopecia associated with combinational use of ficlatuzumab and gefitinib: a clinical and immunohistochemistry study
- Epidermal growth factor receptor inhibitor Geftinib-induced erosive pustular dermatosis of the scalp – A report with a brief review of the literature
- Oral Combination Treatment of Gefitinib (IressaTM) and Sasam-Kyeongokgo: Synergistic Effects on the NCI-H520 Tumor Cell Line
- 증례 : Gefitinib에 의해 유발된 반흔성 탈모증
- Gefitinib
- Tyrosine Kinase Inhibitors – A Review on Pharmacology, Metabolism and Side Effects
- Anti-EGFR mechanism of action: antitumor effect and underlying cause of adverse events.
- Safety Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Disproportionality Analysis of FDA Adverse Event Reporting System
- Scarring alopecia associated with the epidermal growth factor receptor inhibitor erlotinib
- Role for the Epidermal Growth Factor Receptor in Chemotherapy-Induced Alopecia
- Erlotinib-Associated Alopecia in a Lung Cancer Patient
- “PRIDE” Complex
- “Arrow” sign: A rapid microscopic diagnosis of hair change associated with epidermal growth factor receptor inhibitors
- Dermatologic adverse events in EGFR-TKIs: A real-world analysis.
- PRIDE syndrome with lumbosacral hypertrichosis
- Non-small cell lung carcinoma spheroid models in agarose microwells for drug response studies
- Molecular Targeted Agents and Biologic Therapies for Non-small Cell Lung Cancer
- The ophthalmological complications of targeted agents in cancer therapy: what do we need to know as ophthalmologists?
- Target-Adverse Events and Fear of Cancer Progression, Anxiety, and Depression in Patients with Advanced Non-Small Cell Lung Cancer